
Animas Corporation has announced positive results from the second phase of human clinical trials of a first-generation, closed-loop insulin delivery system.
Read more
Animas Corporation has announced positive results from the second phase of human clinical trials of a first-generation, closed-loop insulin delivery system.
Read more